We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a plays a central role in the production of blood cells in the bone marrow. It is assembling a portfoli... Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a plays a central role in the production of blood cells in the bone marrow. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies. Show more
In vitro data showcases CNTY-101βs ability to induce CD19-specific cytolysis of B-cells and potential to treat B-cell driven autoimmune diseases including systemic lupus erythematosus...
- Announced plans to pursue additional autoimmune disease regulatory filings for its iPSC derived NK cell therapy, CNTY-101, beyond systemic lupus erythematosusΒ (SLE) - Closed $60 million private...
PHILADELPHIA, April 23, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies...
Century is pursuing additional autoimmune disease regulatory filings for its iPSC derived iNK cell therapy, CNTY-101, beyond CALiPSO-1 trial in SLE, based on the potential of its differentiated...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.03 | 0.967741935484 | 3.1 | 3.7 | 2.9 | 122331 | 3.12362674 | CS |
4 | -0.88 | -21.9451371571 | 4.01 | 4.07 | 2.75 | 128699 | 3.08999515 | CS |
12 | -1.55 | -33.1196581197 | 4.68 | 5.51 | 2.75 | 198654 | 4.00668753 | CS |
26 | 1.68 | 115.862068966 | 1.45 | 5.51 | 1.28 | 188949 | 3.53201763 | CS |
52 | -0.23 | -6.84523809524 | 3.36 | 5.51 | 1.28 | 148877 | 3.13373877 | CS |
156 | -16.37 | -83.9487179487 | 19.5 | 32.899 | 1.28 | 145711 | 10.25871436 | CS |
260 | -16.37 | -83.9487179487 | 19.5 | 32.899 | 1.28 | 145711 | 10.25871436 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions